PHARMACEUTICAL COMPOSITION CONTAINING ARTEMISIA PRINCEPS

摘要

A pharmaceutical composition containing an Artemisia princeps is provided to induce apoptosis of cells of ovarian cancer and leukemia and suppress the activation of cholesterol acyltransferase. A pharmaceutical composition for preventing and treating cancer comprises (3-(2-methyl-butyryloxy)-costu-1(10),4(5)-dien-12,6-olide) as an active ingredient. The (3-(2-methyl-butyryloxy)-costu-1(10),4(5)-dien-12,6-olide) is isolated from an Artemisia princeps and contained in a ratio of 0.01-99 weight%. The cancer is ovarian cancer and leukemia. A pharmaceutical composition for preventing and treating cardiac circulation diseases comprises the (3-(2-methyl-butyryloxy)-costu-1(10),4(5)-dien-12,6-olide) as an active ingredient. The cardiac circulation diseases are hyperlipidemia, coronary heart disease, arteriosclerosis or myocardial infarction.